NRx Pharmaceuticals (NRXP) News Today $1.57 +0.15 (+10.56%) (As of 05:19 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Insider Buying: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Chairman Acquires 40,000 Shares of StockDecember 19, 2024 | insidertrades.comNRx Pharmaceuticals reiterates shares target with Buy rating on Q3 reportNovember 28, 2024 | uk.investing.comNRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024November 26, 2024 | prnewswire.comNRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"November 25, 2024 | prnewswire.comNRX Pharmaceuticals Strengthens Leadership with New CFO AppointmentNovember 20, 2024 | markets.businessinsider.comNRx Pharmaceuticals Names Michael Abrams CFONovember 20, 2024 | markets.businessinsider.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2024 Earnings Call TranscriptNovember 20, 2024 | msn.comNRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial OfficerNovember 19, 2024 | finanznachrichten.deNRX Pharmaceuticals Inc (NRXP) Q3 2024 Earnings Call Highlights: Significant Reduction in ...November 19, 2024 | uk.finance.yahoo.comNRx Pharmaceuticals names Michael Abrams as CFONovember 19, 2024 | markets.businessinsider.comNRx Pharmaceuticals Reports Progress in Drug DevelopmentNovember 19, 2024 | markets.businessinsider.comNRx Pharmaceuticals, Inc. (NRXP) Q3 2024 Earnings Call TranscriptNovember 18, 2024 | seekingalpha.comNRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial OfficerNovember 18, 2024 | prnewswire.comNRX Pharmaceuticals Advances in Mental Health SectorNovember 15, 2024 | markets.businessinsider.comNRx Pharmaceuticals delays Q3 results call to November 18November 15, 2024 | uk.investing.comNRx Pharmaceuticals files to sell 3.3M shares of common stock for holdersNovember 15, 2024 | markets.businessinsider.comNRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business UpdateNovember 14, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Conference Call to Discuss Third Quarter and Year to Date 2024 Financial Results to November 18, 2024November 13, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter and Year to Date 2024 Financial Results on November 14, 2024November 7, 2024 | prnewswire.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry ClinicsOctober 30, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024October 23, 2024 | globenewswire.comNRx Pharmaceuticals initiated with a Buy at EF HuttonOctober 22, 2024 | markets.businessinsider.comNRX Pharmaceuticals (NASDAQ:NRXP) Stock, Insider Trading ActivityOctober 16, 2024 | benzinga.comNRx Pharmaceuticals Leadership Shift and Strategic Governance DecisionsOctober 13, 2024 | finance.yahoo.comNRx Pharmaceuticals Advances Towards FDA Approval with Key Stability Milestone for NRX-100October 7, 2024 | msn.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric ClinicOctober 3, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)September 30, 2024 | prnewswire.comNRx Pharmaceuticals’ Innovative Treatments for Depression Gain SpotlightSeptember 16, 2024 | msn.comNRX Pharmaceuticals (NASDAQ:NRXP) Stock Quotes, Forecast and News SummarySeptember 11, 2024 | benzinga.comNRX Pharmaceuticals (NASDAQ:NRXP) Stock, Short Interest ReportSeptember 11, 2024 | benzinga.comNRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.comSeptember 11, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024September 3, 2024 | prnewswire.comNRXP Dec 2024 2.000 putAugust 31, 2024 | ca.finance.yahoo.comHOPE Therapeutics Announces $30 Mln Term Sheet From Lender - Quick FactsAugust 26, 2024 | markets.businessinsider.comHOPE Therapeutics Secures Financing For Ketamine Clinic ExpansionAugust 26, 2024 | msn.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry ClinicsAugust 26, 2024 | prnewswire.comNRx Pharmaceuticals Secures $16 Million in Convertible Debt FinancingAugust 19, 2024 | msn.comEarnings call: NRx Pharmaceuticals outlines key business advancementsAugust 18, 2024 | uk.investing.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2024 Earnings Call TranscriptAugust 16, 2024 | msn.comNRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business UpdateAugust 14, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarter and Year to Date 2024 Financial Results on August 14, 2024August 13, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Up to $16 Million Senior Secured Debt Financing from Anson FundsAugust 13, 2024 | prnewswire.comNRx Pharmaceuticals Wins Arbitration to Proceed with HOPE Therapeutics SpinoffAugust 6, 2024 | msn.comNRx Pharmaceuticals cleared for HOPE Therapeutics spinoffJuly 31, 2024 | investing.comNRx Pharmaceuticals, Inc.: HOPE Therapeutics, Inc. and NRx Pharmaceuticals (Nasdaq:NRXP) Announce Arbitration Order Enabling HOPE Therapeutics SpinoffJuly 30, 2024 | finanznachrichten.deNRx Pharma, HOPE Therapeutics Align With FDA On Pediatric Study Plan For NRX-100July 30, 2024 | markets.businessinsider.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100 (ketamine)July 29, 2024 | prnewswire.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals (Nasdaq:NRXP) Announce Arbitration Order Enabling HOPE Therapeutics SpinoffJuly 29, 2024 | prnewswire.comNRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update LetterJuly 1, 2024 | prnewswire.comNRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for FilingJune 28, 2024 | prnewswire.com Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address No one’s talking about these Trump trades (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.” Go here to see how you can start accessing these opportunities today NRXP Media Mentions By Week NRXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRXP News Sentiment▼1.310.55▲Average Medical News Sentiment NRXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRXP Articles This Week▼22▲NRXP Articles Average Week Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aadi Bioscience News Kronos Bio News Spero Therapeutics News Invivyd News Immuneering News Immix Biopharma News Shattuck Labs News AlloVir News IO Biotech News Celularity News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRXP) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredSix Stocks That Could Soar on Trump’s First Day BackThe recent election results have clarified a path forward, creating opportunities that weren't as clear just m...InvestorPlace | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
